Europe Electrophysiology Market Research Report - Segmented By Product, By Indication And By Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029)

Updated On: January, 2024
ID: 3804
Pages: 137

Europe Electrophysiology Market Size (2023 to 2028)

The size of the Europe Electrophysiology Market was valued at USD 2.05 billion in 2023 and is estimated to be growing at a CAGR of 9.43% to reach USD 3.22 billion by 2028.

The primary factor driving the European electrophysiology market is the rising prevalence of targeted diseases. According to the World Health Organization, Cardiovascular diseases are the leading cause of death in the region, which is demanding electrophysiology in treatment procedures. The technological advancements in electrophysiology and growing demand for catheter ablation procedures are propelling the region's market value growth. According to the European Society of Cardiology, nearly 11 million cardiovascular disease cases are reported annually in Europe. Cardiovascular diseases are responsible for the death of around 3.6 million people in Europe annually. Since electrophysiology devices are highly adopted to detect heart failure rates, growing cardiovascular cases are expected to boost market growth in the region over the forecast period. 

The increasing approvals for electrophysiology devices by the government and regulatory authorities are augmenting the market growth. For Instance, in 2022, Abbott Laboratories announced the US Food and Drug Administration had given clearance for the EnSite X EP system with EnSite omnipolar technology for treating atrial Fibrillation. The growing prevalence of chronic diseases like hypertension, diabetes, and thyroids is estimated to fuel the market growth.

The rising developments and innovations in electrophysiology technology, where ablation catheters are being introduced into the market, which are cost-effective and provide early diagnosis, are expected to provide market growth opportunities during the forecast period. The increasing product approvals and launches into the market by the market players are efficient, and the researchers are focusing on deon developing more efficient and cost-effective products, which are estimated to witness market growth during the forecast period.

According to the European Union of Medical Specialists, only a few cardiologists specialize in electrophysiology, which is expected to limit the adoption of electrophysiology. Due to this, the electrophysiology workforce is stable in the European region. The stringent regulation policies by the regulatory authorities of Europe and the adoption of electrophysiology are estimated to impede market expansion. The procedure's high cost, which is difficult to afford for the low economic population, is also expected to hamper the market growth. 

The major market expansion challenge is the inability to localize the cell type, which generates the signal in the in-vivo electrophysiology. The electrophysiology testing cannot differentiate intraneural pathology from extraneural nerve compression, which is crucial as extraneural nerve compression has a worse prognosis. Another challenging factor impeding the market expansion is the false negative results in peripheral nerve disorders.

Impact of COVID-19 on the Europe Electrophysiology Market:

The pandemic negatively impacted Europe's antrophysiology market as most non-emergency surgeries are postponed to provide healthcare for COVID-19 patients. According to a research article in the European Heart Journal in 2020, Atrial Fibrillation is one of the most common cardiovascular diseases observed in European people. According to the symptoms, patients with atrial Fibrillation are highly prone to catching the SARS-CoV-2 virus. According to an article in the Journal of Cardiovascular Pharmacology, 2020, the drugs used in atrial Fibrillation and the experimental therapies used for COVID-19 are resulting in limited clinical practice, as the drug interactions are causing electrocardiographic abnormalities.

This research report has been segmented and sub-segmented the European Electrophysiology Market into the following categories:

By Product:

  • Electrophysiology Ablation Catheters
  • Electrophysiology Diagnostic Catheters
  • Electrophysiology Laboratory Devices
  • Access Devices

The electrophysiology ablation catheters segment held the largest share and is expected to dominate over the forecast period. The ablation catheters remove the abnormal heart tissues, causing irregular heartbeats. This minimally invasive procedure allows the catheters to demolish the defective electrical pathways from the heart. The most frequently used ablation catheters are radiofrequency type and cryoablation, which are highly efficient with technology advancements that enhance the market growth in the forecast period.

The electrophysiology laboratory devices and diagnostic catheters segment is expected to grow significantly during the forecast period due to the rising prevalence of cardiovascular diseases. 

By Indication:

  • Atrial Flutter
  • Atrial Fibrillation
  • Wolff-Parkinson-White Syndrome
  • Atrioventricular Nodal Re-entry Tachycardia
  • Other Indications

The Atrial Fibrillation segment dominated the European electrophysiology market and is expected to be the fastest-growing segment during the forecast period. Atrial Fibrillation is the most common type of arrhythmia, which results in irregular and rapid heart rhythms. The growing prevalence of atrial Fibrillation, the efficient number of ablation procedures, and the rising geriatric population are driving market revenue growth in this segment.

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Europe held the second position in the global electrophysiology market, whereas Germany and the UK held the largest share in the European electrophysiology market. European region held the top position for its healthcare infrastructure, and the advancements in the technology of electrophysiology devices are boosting the market growth opportunities in the European countries. The growing number of seniors with chronic cardiovascular conditions is estimated to fuel the market value. France and Italy are holding a steady growth rate in the regional market and are projected to maintain the growth in the forecast period. The substantial lifestyle of people with an unbalanced diet is resulting in cardiovascular diseases, which is enhancing the adoption of electrophysiology in Europe.


Key players operating in the Europe Electrophysiology Market profiled in this report are Boston Scientific Corporation (U.S.), GE Healthcare (U.K.), Abbott Laboratories (U.S.), Biosense Webster, Inc. (U.S.), Microport Scientific Corporation (China), St. Jude Medical, Inc. (U.S.), BIOTRONIK SE & Co. KG (Germany), Koninklijke Philips N.V. (The Netherlands), Medtronic, Inc. (U.S.), and Siemens AG (Germany).

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample